SCHEMBL8480067

SCHEMBL8480067

Cc1ccc(-c2cc(-c3ccccc3)nc(-c3cccc(N)c3)c2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.69
▸ KMT2A Q03164 6/20 0.69
▸ ALDH1A1 P00352 7/20 0.61
▸ HPGD P15428 7/20 0.61
▸ KDM4E B2RXH2 7/20 0.61
▸ MAPT P10636 6/20 0.61
▸ LMNA P02545 2/20 0.61
▸ GLA P06280 1/20 0.60
▸ TDP1 Q9NUW8 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ AGTR1 P30556 1/20 0.53
▸ MAOA P21397 1/20 0.52
▸ NPC1 O15118 4/20 0.50
▸ RAB9A P51151 4/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ GAA P10253 1/20 0.50
▸ ADORA2A P29274 2/20 0.49
▸ ADORA1 P30542 2/20 0.49
▸ TSHR P16473 1/20 0.49
▸ RECQL P46063 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15684033 0.90 MEN1 (0.73) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL8480251 0.89 MEN1 (0.76) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL14389682 0.88 MEN1 (0.70) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL16376447 0.87 MEN1 (0.77) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL16376448 0.87 MEN1 (0.77) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL20413823 0.87 MEN1 (0.77) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL28047012 0.87 MEN1 (0.77) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL20220277 0.87 MEN1 (0.77) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL4357711 0.87 MEN1 (0.77) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL12655454 0.87 MEN1 (0.77) MEN1KMT2AALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5922743-A USEFUL FOR AMELIORATION OF NERVE DISORDERS DUE TO NEURONAL DEGENERATION, SUCH AS INDUCED BY DRUGS OR ALCOHOL, INFLAMMATORY DISORDERS, DIABETES, ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, HUNTINGTON'S CHOREA, AND OTHERS TAISHO PHARMACEUTICAL CO., LTD. (JP) 1999-07-13 — — US disclosed
EP-0795545-A1 PYRIDINE DERIVATIVES TAISHO PHARMACEUTICAL CO. LTD (JP) 1997-09-17 — — EP disclosed
Send feedback